LUCID DIAGNOSTICS INC. LUCD 深 沪
等待开盘 08-05 09:30:00 美东时间
1.04
+0.040
+4.00%
华盛通- 最 高1.05
- 今 开1.04
- 成交量 24.17万股
- 最 低 1.0004
- 昨 收 1.00
- 总市值 1.12亿
- 52周最高 1.80
- 市盈率 静 --
- 换手率 0.22%
- 52周最低 0.73
- 委 比 -34.79%
- 总股本 1.08亿
- 历史最高 13.52
- 量 比 0.44
- 振 幅 4.96%
- 历史最低 0.6301
- 每 手 1
- 风险率 0.26%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多PAVmed gets 180-day extension to regain Nasdaq listing compliance
PAVmed (NASDAQ:PAVM) has been granted a 180-day extension to regain compliance with the $1.00 minimum bid price requirement under the Nasdaq listing rule. The company now has until January 19, 2026 to...
07-30 20:16
Lucid nearing Medicare coverage for EsoGuard test, maintain at Buy: BTIG
Lucid Diagnostics' (NASDAQ:LUCD) EsoGuard test could get Medicare coverage soon, according to recent commentary from BTIG analysts. Analysts at BTIG said that during a day of investor meetings with L...
07-29 02:36
Lucid Diagnostics, a PAVmed Subsidiary, Nears Medicare Decision on EsoGuard Cancer Test
Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced that on
07-16 19:35
美股大行评级 | 潜在涨幅925.64%！Aemetis获Ascendiant Capital升目标价至20美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1138028221594226688.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Ascendiant Capital：维持Aemetis(AMTX)"买入"评级，目标价从19美元升至20美元</p> <p>• Ascendiant Capital：维持Lucid Diagnostics(LUCD)"买
06-07 08:37
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Lyra Therapeutics (NASDAQ:LYRA) shares moved upwards by 463.3% to $27....
06-02 20:07
Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket
Shares of Blueprint Medicines Corporation (NASDAQ:BPMC) rose sharply in today's...
06-02 19:29
Lucid Diagnostics Enters $25M Sales Agreement
Lucid Diagnostics ( ($LUCD) ) has shared an update. On May 30, 2025, Lucid Diag...
05-31 05:05
Lucid Diagnostics to Join Russell 2000® and Russell 3000® Indexes
NEW YORK, May 27, 2025 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of ...
05-27 19:31
美股大行评级 | 潜在涨幅1281.22%！Cabaletta Bio获Guggenheim升目标价至25美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130057143861719040.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Cabaletta Bio(CABA)"买入"评级，目标价从23美元升至25美元</p> <p>• 瑞穗：维持Tectonic Therapeutic(TECX)"跑赢大市"评级，目标价从51美元
05-16 08:43
